Fabio Chianelli
Chairman and Chief Executive Officer
Mr. Chianelli has over 15 years of experience with specialty life sciences companies. He was the Founder and President of Revive Therapeutics Ltd. (CSE: RVV) between 2012 and 2019. From January 2000 to January 2012, Mr. Chianelli held senior roles in investor relations, business development, and marketing and sales with Generex Biotechnology Corporation. Mr. Chianelli received his Bachelor of Commerce from Ryerson University.
Carmelo Marrelli
Chief Financial Officer
Mr. Marrelli holds a Bachelor of Commerce degree from the University of Toronto and is qualified as a Chartered Accountant and as a Certified General Accountant in Canada. Mr. Marrelli has been a principal of Marrelli Support Services Inc., a firm providing administration services to Canadian public companies, since February 2009 and, prior to February 2009, a partner with Marrelli & Drake Corporate Services (formerly Duguay & Ringler Corporate Services) (a firm providing administration services to Canadian public companies). Mr. Marrelli also serves as the Chief Financial Officer of several publicly-listed junior mining companies and as a director of Odyssey Resources Limited, an Exchange listed issuer.
Dr. Owen Van Cauwenberghe, PhD
VP, Pharmaceutical Development
An established leader and innovator with over 19 years of experience in the pharmaceutical and biotechnology sectors with a wide range of industry expertise in brand and generic strategic definition, organizational design, product / analytical / formulation development, project management, product innovation and commercialization. Founding Partner, President and COO of Bio Therapeutic Molecules Inc., Adjunct Associate Professor in the Waterloo School of Pharmacy, President and Board Member at MedC Biopharma, Expert Advisory Board Member at MMGenetics, former Chief Research Officer at AgMedica Bioscience Inc., former Director at Accucaps Industries Ltd. and former Principal Research Scientist and Director at Eli Lilly Canada.
